Kidney Research and Clinical Practice

Author index

Page Path

9 Articles

Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future: Do Hyoung Kim, Young Youl Hyun, Jin Joo Cha et al.; Kidney Res Clin Pract. 2024;43(1):8-19. Published online January 31, 2024; DOI: https://doi.org/10.23876/j.krcp.23.232
Web of Science 1 Cited By 1; Full text PubReader ePub PDF

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy: Sang Youb Han, Chan-Young Jung, Sang Ho Lee et al.; Kidney Res Clin Pract. 2022;41(4):452-461. Published online May 4, 2022; DOI: https://doi.org/10.23876/j.krcp.21.146
Web of Science 2 Cited By 4; Full text PubReader ePub PDF Supplementary Material

Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy: Sang Youb Han, Kyung Hwan Jeong, Chun-Gyoo Ihm, Young Sun Kang, Dae Ryong Cha; Kidney Res Clin Pract. 2021;40(1):69-76. Published online March 12, 2021; DOI: https://doi.org/10.23876/j.krcp.20.157
Web of Science 4 Cited By 4; Full text PubReader ePub PDF Supplementary Material

Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey: Ran-hui Cha, Su Hyun Kim, Eun Hui Bae et al.; Kidney Res Clin Pract. 2019;38(3):373-381. Published online September 30, 2019; DOI: https://doi.org/10.23876/j.krcp.19.007
Web of Science 4 Cited By 4; Full text PubReader PDF Supplementary Material

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pag: Ran-hui Cha, Shin Wook Kang, Cheol Whee Park et al.; Kidney Res Clin Pract. 2018;37(1):98-99. Published online March 31, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.1.98; Full text PubReader PDF

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis: Sollip Kim, Hyun-Jung Kim, Hyeong-Sik Ahn et al.; Kidney Res Clin Pract. 2017;36(3):274-281. Published online September 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.3.274
Web of Science 40 Cited By 37; Full text PubReader PDF Supplementary Material

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea: Ran-hui Cha, Shin Wook Kang, Cheol Whee Park et al.; Kidney Res Clin Pract. 2017;36(1):68-78. Published online March 31, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.1.68
Web of Science 33 Cited By 31; Full text PubReader PDF Supplementary Material

Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway: Jin Joo Cha, Young Youl Hyun, Yi Hwa Jee et al.; Kidney Res Clin Pract. 2012;31(3):177-185. Published online June 26, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.06.004
Cited By 6; Full text PubReader PDF

Pan-Nox inhibitor treatment improves renal function in aging murine diabetic kidneys: Jeong Hoon Park, Sung Gi Yoon, Jung Yeon Ghee et al.; Received January 4, 2023 Accepted April 22, 2023 Published online August 10, 2023; [Epub ahead of print]
Cited By 1; Full text PubReader ePub PDF

14,948	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,887	C4d Puzzle in ABO-incompatible kidney transplantation
8,365	How should we treat acute kidney injury caused by renal congestion?
13,088	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
35,217	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 15	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis